Clinical Trials Browser

Interventional × Lymphoma × VTX-2337 × Clear all

NCT00688415 2019-09-25

Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer

Phase 1 Completed

Lymphoma

NCT01289210 2019-09-25

VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas

Phase 1/2 Terminated

2 enrolled 4 charts

Lymphoma